Taysha Gene Therapies, Inc. TSHA Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s earnings yield?
- Taysha Gene Therapies, Inc. (TSHA) reported earnings yield of -10.1% in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s earnings yield changed year-over-year?
- Taysha Gene Therapies, Inc.'s earnings yield increased by 66.8% year-over-year, from -30.4% to -10.1%.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s earnings yield?
- Over 4 years (2020 to 2025), Taysha Gene Therapies, Inc.'s earnings yield has grown at a 0.8% compound annual growth rate (CAGR), from -7% to -7.2%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.